Mechanisms and funding opportunities in genitourinary cancer clinical research

Christopher W. Ryan

doi:10.1016/j.urolonc.2018.05.024

Mechanisms and funding opportunities in genitourinary cancer clinical research

Research output: Contribution to journal › Review article › peer-review

Abstract

Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.

Original language	English (US)
Pages (from-to)	318-323
Number of pages	6
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	37
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2018.05.024
State	Published - May 2019

Keywords

Clinical trials
Cooperative Groups
Funding
NCTN
Urologic cancers

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.urolonc.2018.05.024

Cite this

@article{28c5d9ff3ad943808efacfbccaa8ec52,

title = "Mechanisms and funding opportunities in genitourinary cancer clinical research",

abstract = "Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.",

keywords = "Clinical trials, Cooperative Groups, Funding, NCTN, Urologic cancers",

author = "Ryan, {Christopher W.}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2019",

month = may,

doi = "10.1016/j.urolonc.2018.05.024",

language = "English (US)",

volume = "37",

pages = "318--323",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Mechanisms and funding opportunities in genitourinary cancer clinical research

AU - Ryan, Christopher W.

PY - 2019/5

Y1 - 2019/5

N2 - Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.

AB - Progress in the prevention, diagnosis, and treatment of genitourinary cancers is dependent on well-conducted clinical trials. The complexity and cost of clinical research continues to escalate, and success is dependent on adequate funding. Opportunities to fund such research include federal, industry, and private sources. The mechanisms whereby larger trials are conducted include contract research organizations, publically- and privately funded consortia, and the National Clinical Trials Network of the National Cancer Institute. The National Clinical Trials Network is the prime venue for investigators to conduct independent, phase III trials in the United States.

KW - Clinical trials

KW - Cooperative Groups

KW - Funding

KW - NCTN

KW - Urologic cancers

UR - http://www.scopus.com/inward/record.url?scp=85050978284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050978284&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2018.05.024

DO - 10.1016/j.urolonc.2018.05.024

M3 - Review article

C2 - 30072304

AN - SCOPUS:85050978284

SN - 1078-1439

VL - 37

SP - 318

EP - 323

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -

Mechanisms and funding opportunities in genitourinary cancer clinical research

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this